Target Name: C10orf55
NCBI ID: G414236
Review Report on C10orf55 Target / Biomarker Content of Review Report on C10orf55 Target / Biomarker
C10orf55
Other Name(s): Uncharacterized protein C10orf55 | bA417O11.3 | chromosome 10 putative open reading frame 55 | CJ055_HUMAN | Chromosome 10 open reading frame 55

Unraveling the Potential Applications of C10orf55: A novel Uncharacterized Protein as a Drug Target and Biomarker

Introduction

C10orf55 is a non-coding RNA molecule located in chromosome 10p36.5, which has been shown to play a crucial role in various cellular processes. Its unique structure and unique gene location have piqued the interest of researchers, who are trying to uncover its functions . Recently, studies have identified its potential as a drug target and biomarker. In this article, we will explore the biology of C10orf55, its potential applications as a drug target, and its potential as a biomarker for various diseases.

The Biology of C10orf55

C10orf55 is a small non-coding RNA molecule that is located in chromosome 10p36.5. It is characterized by a unique structure, which consists of a 19-amino acid protein coded by the gene and a non-coding region that is primarily responsible for its regulation.

The unique structure of C10orf55 has led to its high-resolution mass spectrometry analysis and bioinformatics predictions suggest that it may be an important gene regulator. In addition, the expression pattern of C10orf55 in cells also indicates that it plays an important role in a variety of biological processes.

Protein function of C10orf55

The protein function of C10orf55 can be elucidated in several ways. First of all, it is an RNA-binding protein that can bind to a variety of RNA molecules in cells, thereby participating in gene expression and regulation. Secondly, C10orf55 has a conserved secondary structure in cells, indicating that it may be an important structural protein. Finally, the protein expression levels of C10orf55 vary in different cell types, suggesting that it plays different roles in different biological processes.

Pharmacological applications of C10orf55

The pharmacological applications of C10orf55 mainly focus on two aspects: as a drug target and as a biomarker.

As a drug target, the protein expression level of C10orf55 can affect various biological processes in cells by regulating gene expression. By interfering with the protein expression of C10orf55, various diseases can be treated, such as cancer, neurodegenerative diseases, etc. In addition, the protein expression level of C10orf55 can also be used as a monitoring indicator of drug efficacy.

As a biomarker, C10orf55 can be used to detect a variety of diseases, such as cancer, neurodegenerative diseases, etc. By monitoring the protein expression level of C10orf55, the existence of the disease can be detected early and provide a basis for the treatment of the disease.

Biological applications of C10orf55

The biological applications of C10orf55 mainly involve tumor biology. The protein expression level of C10orf55 can be used as an important biological indicator of tumor occurrence and development. Studies have shown that the expression level of C10orf55 is closely related to the occurrence and development of various tumors, providing an important theoretical basis for the study of tumor biology.

C10orf55 can also serve as a new drug target. By regulating the protein expression of C10orf55, the growth and spread of tumor cells can be inhibited, thereby providing new ideas and methods for tumor treatment.

Conclusion

C10orf55 is a non-coding RNA molecule located in chromosome 10p36.5 that has unique structure and functions. Its potential applications as a drug target and biomarker have piqued the interest of researchers, and further studies are needed to fully understand its biology and significance .

Protein Name: Chromosome 10 Putative Open Reading Frame 55

The "C10orf55 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C10orf55 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C10orf62 | C10orf67 | C10orf71 | C10orf71-AS1 | C10orf82 | C10orf88 | C10orf88B | C10orf90 | C10orf95 | C10orf95-AS1 | C11orf16 | C11orf21 | C11orf24 | C11orf40 | C11orf42 | C11orf52 | C11orf54 | C11orf58 | C11orf65 | C11orf68 | C11orf71 | C11orf80 | C11orf86 | C11orf87 | C11orf91 | C11orf96 | C11orf97 | C11orf98 | C12orf29 | C12orf4 | C12orf40 | C12orf42 | C12orf43 | C12orf50 | C12orf54 | C12orf56 | C12orf57 | C12orf60 | C12orf74 | C12orf75 | C12orf76 | C13orf42 | C13orf46 | C14orf119 | C14orf132 | C14orf178 | C14orf180 | C14orf28 | C14orf39 | C14orf93 | C15orf32 | C15orf39 | C15orf40 | C15orf48 | C15orf61 | C15orf62 | C16orf46 | C16orf54 | C16orf74 | C16orf78 | C16orf82 | C16orf86 | C16orf87 | C16orf89 | C16orf90 | C16orf92 | C16orf95 | C16orf96 | C17orf100 | C17orf107 | C17orf49 | C17orf50 | C17orf58 | C17orf67 | C17orf75 | C17orf78 | C17orf80 | C17orf97 | C17orf98 | C17orf99 | C18orf21 | C18orf25 | C18orf32 | C18orf54 | C18orf63 | C19orf12 | C19orf18 | C19orf25 | C19orf33 | C19orf38 | C19orf44 | C19orf47 | C19orf48 | C19orf53 | C19orf67 | C19orf73 | C19orf81 | C19orf84 | C1D | C1GALT1